Assessment of iron stores in children with transfusion siderosis by biomagnetic liver susceptometry

American Journal of Hematology

Volumn 60, Issue 4, 1999, Pages 289-299

  Fischer, Roland ^a   Tiemann, Christian D ^a   Engelhardt, Rainer ^a   Nielsen, Peter ^a   Dürken, Matthias ^a   Gabbe, Erich E ^a   Janka, Gritta E ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Biomagnetometry; Chelation therapy; Children; Iron; SQUID; Thalassemia

Indexed keywords

DEFERIPRONE; DEFEROXAMINE;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; CHELATION; CHILD; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; FERRITIN BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; IRON KINETICS; IRON STORAGE; ORGAN SIZE; PRIORITY JOURNAL; SIDEROSIS; STEADY STATE; THALASSEMIA;

ADOLESCENT; ADULT; ANIMALS; BETA-THALASSEMIA; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; FERRITINS; HUMANS; INTESTINES; IRON; LIVER; LUNG; MAGNETICS; SIDEROSIS; SPLEEN;

EID: 0032954376     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199904)60:4<289::AID-AJH7>3.0.CO;2-W     Document Type: Article

References (45)

1. Modell CB. Transfusional haemochromatosis. In: Kief H, editor. Iron metabolism and its disorders. Amsterdam: Excerpta; 1975. p 230-240.
2. Brittenham GM. Noninvasive methods for the early detection of hereditary hemochromatosis. Ann NY Acad Sci 1988;526:199-208.
3. Brittenham GM, Farrell DE, Harris JW, Feldman ES, Danish EH, Muir WA, Tripp JH, Bellon EM. Magnetic susceptibility measurement of human iron stores. N Engl J Med 1982;307:1671-1675.
4. Fischer R, Engelhardt R, Nielsen P, Gabbe EE, Heinrich HC, Schmiegel WH, Wurbs D. Liver iron quantification in the diagnosis and therapy control of iron overload patients. In: Hoke M, Erné SN, Okada YC, Romani GL, editors. Biomagnetism: clinical aspects. Amsterdam: Elsevier; 1992. p 585-588.
5. Fischer R, Piga A, Tricta F, Nielsen P, Engelhardt R, Garofalo F, Di Palma A, Vullo C. The use of biomagnetic liver susceptometry in the Ferrara-Hamburg-Turin study on thalassemia. In: Aine CJ, Okada YC, Stroink G. Swithenby SJ, Wood C, editors. BIOMAG96: Advances in Biomagnetism Research. New York: Springer; 1998. (in press).
6. Hartmann W, Schneider L, Wirth A, Dördelmann M, Zinser D, Elias H, Languth W, Ludwig W, Kleihauer E. Liver susceptometry for the follow up of transfusional iron overload. In: Hoke M, Erné SN, Okada YC, Romani GL, editors. Biomagnetism: clinical aspects. Amsterdam: Elsevier; 1992. p 589-593.
7. Modell B, Berdoukas V. The clinical approach to thalassemia. London: Grune & Stratum; 1984. p 163-169, 215.
8. Nielsen P, Fischer R, Engelhardt R, Tondüry P, Gabbe EE, Janka GE. Liver iron stores in patients with secondary haemochromatosis under iron chelation therapy with deferoxamine or deferiprone. Br J Haematol 1995;91:827-833.
9. Paulson DN, Fagaly RL, Toussaint RM, Fischer R. Biomagnetic susceptometer with SQUID instrumentation. Inst Electr Electron Eng Trans Magn 1991;27:3249-3252.
10. Fischer R. Liver iron susceptometry. In: Andrae W, Nowak H, editors. Magnetism in medicine: a handbook. Berlin: Wiley-VCH; 1998. p 286-301.
11. Shoden A, Sturgeon P. Hemosiderin - a physico-chemical study. Acta Haematol 1960;23:376-392.
12. Leung NWY, Farrant P, Peters TJ. Liver volume measurement by ultrasonography in normal subjects and alcoholic patients. J Hepatol 1986;2:157-164.
13. Modell CB, Beck J. Long-term desferrioxamine therapy in thalassemia. Ann NY Acad Sci 1974;232:201-210.
14. Brittenham GM, Allen CJ, Farrell DE, Harris JW. Hepatic iron stores in thalassemia: non-invasive magnetic measurements. Prog Clin Biol Res 1989;309:101-106.
15. Rasmussen N. Liver volume determination by ultrasonic scanning. Dan Med Bull 1978;25:1-45.
16. Tiemann C. Biomagnetometrische Speichereisen-Bestimmung: Therapiekontrolle bei Kindern mit Transfusionssiderosen [Thesis]. University Hamburg; 1995. p 28-30.
17. Brittenham GN, Cohen AR, McLaren CE, Martin MB, Griffith PM, Nienhus AW, Young NS, Allen CJ, Farrell DE, Harris JW. Hepaticiron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major. Am J Hematol 1993;42:81-85.
18. De Virgilis S, Sanna G, Cornacchia G, Argiolu F, Murgia V, Porcu M, Cao. Serum ferritin, liver iron stores, and liver histology in children with thalassemia. Arch Dis Child 1980;55:43-45.
19. Worwood M, Cragg SJ, Jacobs A, McLaren C, Ricketts C, Economidou J. Binding of serum ferritin to concanavalin A: patients with homozygous β thalassemia and transfusional iron. Br J Haematol 1980;46:409-416.
20. Hentze MW, Kuehn LC, Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci USA 1996;93:8175-8182.
21. Ponka P, Beaumont C, Richardson. Function and regulation of transferrin and ferritin. Blood 1998;35:35-54.
22. Linder MC, Schaffer KJ, Hazegh-Azam M, Zhou CY, Tran TN, Nagel GM. Serum ferritin: does it differ from tissue ferrilin? J Gastroenterol Hepatol 1996;11:1033-1036.
23. Barry M, Flynn DM, Letsky EA, Risdon RA. Long-term chelation therapy in thalassemia major: effect on liver iron concentration, liver histology, and clinical progress. Br Med J 1974;2:16-20.
24. ICRP Publication 23. Reference man: anatomical, physiological and metabolic characteristics. Oxford: Pergamon; 1975, table 105.
25. Cazzola M, Borgna-Pignatti C, De Stefano P, Bergamaschi G, Bongo IG, Dezza L, Avato F. Internal distribution of excess iron and sources of serum ferritin in patients with thalassemia. Scand J Haematol 1983; 30:289-296.
26. Buja LM, Roberts WC, Iron in the heart. Am J Med 1971;51:209-220.
27. Bezwoda WR, Bothwell TH, Torrance JD, MacPhail AP, Charlton RW. Kay G, Levin J. The relationship between marrow iron stores and plasma ferritin concentrations and iron absorption. Scand J Haematol 1979;22:113-120.
28. Gorodetski R, Loewenthal E, Goldfarb A, Rachmilewitz EA. Noninvasive evaluation of iron load and clearance in patients with β-thalassemia. Ann NY Acad Sci 1990;612:568-572.
29. Summers KM, Halliday JW, Powell LW, Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index. Hepatology 1990;12:20-25.
30. Bannerman RM, Callender ST, Hardisty RM, Smith RS. Iron absorption in thalassemia. Br J Haematol 1964;10:490-495.
31. Pippard MJ, Callender ST, Warner GT, Weatherall DJ. Iron absorption in iron-loading anaemias: effect of subcutaneous desferrioxamine infusions. Lancet 1977;i:737-739.
32. Pootrakul P, Kitcharoen K, Yansukon P, Wasi P, Fucharoen S, Charoenlarp P, Brittenham G, Pippard MJ, Finch CA. The effect of erythroid hyperplasia on iron balance. Blood 1988;71:1124-1129.
33. Alarcon PA, Donovan ME, Forbes GB, Landaw SA, Stockman JA. Iron absorption in the thalassemia syndromes and its inhibition by tea. N Engl J Med 1979;300:5-8.
34. Heinrich HC, Gabbe EE, Oppitz KH, Whang DH, Bender-Götze C, Schäfer KH, Schröter W, Pfau AA. Absorption of inorganic and food iron in children with heterozygous and homozygous β-thalassemia. Z Kinderheilk 1973;115:1-22.
35. Erlandson ME, Walden B, Ster G, Hilgartner MW, Wehman J, Smith CH. Studies on congenital hemolytic syndromes: IV. Gastrointestinal absorption of iron. Blood 1962;19:359-378.
36. Gabutti V, Piga A, Fortina P, Miniero R, Nicola P. Correlation between transfusion requirement, blood volume and haemoglobin level in homozygous β-thalassemia. Acta Haematol 1980;64:103-108.
37. Green R, Charlton R, Seftel H, Bothwell T, Mayet F, Adams B, Finch C, Layrisse M. Body iron excretion in man. Am J Med 1968;45:336-353.
38. Malamos B, Constantoulakis M, Gyftaki E, Kesse-Elias M, Augoustaki O. Urinary and faecal iron excretion in thalassemia syndromes. Acta Haematol 1969;42:321-329.
39. Politi P, Lucarelli G, Capriotti L, Salvadori P, Dardanelli C, Barbanti I. Liver iron stores before and after bone marrow transplantation for thalassemia. Prog Clin Biol Res 1989;309:281-289.
40. Propper RD, Cooper B, Rufo RR, Nienhuis AW, French Anderson W, Franklin Bunn H, Rosenthal A, Nathan DG. Continuous subcutaneous administration of desferrioxamine in patients with iron overload. N Engl J Med 1977;297:418-423.
41. Pippard MJ, Callender ST, Weatherall DJ. Intensive iron-chelation therapy with desferrioxamine in iron-loading anaemias. Clin Sci Mol Med 1978;4:99-106.
42. Pippard MJ, Callender ST, Letsky EA, Weatherall DJ. Prevention of iron loading in transfusion-dependent thalassemia. Lancet 1978;i: 1178-1181.
43. Janka GE, Móhring P, Helmig M, Haas RJ, Betke K. Intravenous and subcutaneous desferrioxamine therapy in children with severe iron overload. Eur J Pediatr 1981;137:285-290.
44. Pippard MJ, Callended ST, Finch CA. Femoxamine excretion in iron loaded man. Blood 1982;60:288-294.
45. Fargion S, Taddei MT, Gabutti V, Piga A, Di Palma A, Capra L, Fontanelli G, Avanzini A. Early iron overload in beta-thalassemia major: when to start chelation therapy? Arch Dis Childhood 1982;57: 929-933.